Premium
Pathophysiology of lymphedema—Is there a chance for medication treatment?
Author(s) -
Hespe Geoffrey E.,
Nores Gabriela Garcia,
Huang JungJu,
Mehrara Babak J.
Publication year - 2017
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.24414
Subject(s) - lymphedema , medicine , quality of life (healthcare) , pathophysiology , disease , cancer , secondary lymphedema , surgery , intensive care medicine , breast cancer , nursing
Lymphedema is a common morbid after cancer treatment. The disease characterizes with progressive inflammatory process that result in irreversible fibrosis. Its chronology and progressive disease character often impacts the quality of life of cancer survivors. The pathophysiology of lymphedema remains unclear and the disease remains non‐curable. In this article, we reviewed available studies of lymphedema and concluded possible treatment strategies for lymphedema. J. Surg. Oncol. 2017;115:96–98 . © 2016 Wiley Periodicals, Inc.